| 000 | 01247 a2200409 4500 | ||
|---|---|---|---|
| 005 | 20250511125254.0 | ||
| 264 | 0 | _c19790816 | |
| 008 | 197908s 0 0 eng d | ||
| 022 | _a0098-7484 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHerron, A | |
| 245 | 0 | 0 |
_aInfluenza vaccination in patients with rheumatic diseases. Safety and efficacy. _h[electronic resource] |
| 260 |
_bJAMA _cJul 1979 |
||
| 300 |
_a53-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 |
_aAntibodies, Viral _xanalysis |
| 650 | 0 | 4 |
_aAntibody Formation _xdrug effects |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xcomplications |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucocorticoids _xpharmacology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aInfluenza Vaccines _ximmunology |
| 650 | 0 | 4 |
_aLupus Erythematosus, Systemic _xcomplications |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRheumatic Diseases _xcomplications |
| 650 | 0 | 4 | _aRisk |
| 650 | 0 | 4 | _aVaccination |
| 700 | 1 | _aDettleff, G | |
| 700 | 1 | _aHixon, B | |
| 700 | 1 | _aBrandwin, L | |
| 700 | 1 | _aOrtbals, D | |
| 700 | 1 | _aHornick, R | |
| 700 | 1 | _aHahn, B | |
| 773 | 0 |
_tJAMA _gvol. 242 _gno. 1 _gp. 53-6 |
|
| 999 |
_c338198 _d338198 |
||